Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis

Salari, Nader; Darvishi, Niloofar; Hemmati, Mahvan; Shohaimi, Shamarina; Ghyasi, Yasaman; Hossaini, Farahnaz; Bazrafshan, Mohammad‐Rafi; Akbari, Hakimeh; Mohammadi, Masoud

doi:10.1007/s00705-022-05382-1

Cited by 18 publications

(11 citation statements)

References 97 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Notably, calf pain, low back pain, and pelvic girdle pain were the most commonly reported dysfunctions during the second trimester [16]. A meta-analysis reported a global prevalence of back pain in the first, second, and third trimesters as 28.3%, 36.8%, and 47.8%, respectively [17]. These findings underscore the dynamic nature of musculoskeletal discomfort throughout pregnancy, emphasizing the importance of tailored interventions for pregnant individuals across different stages of gestation.…”

Section: Discussionmentioning

confidence: 90%

Investigating Musculoskeletal Pain Among Pregnant Women in Dhaka Division: A Cross-Sectional Study

Uddin,

Shumi

2024

Preprint

View full text Add to dashboard Cite

Objectives This study aimed to investigate musculoskeletal pain among pregnant women in Dhaka Division, Bangladesh, considering demographic factors, pain and pregnancy-related experiences. Materials and Methods Data were collected from 300 pregnant women attending outpatient clinical check-ups at two hospitals in Dhaka Division, Bangladesh. A standardized questionnaire covering demographic information, pregnancy-related inquiries, and pain assessment using the Numeric Pain Rating Scale (NPRS) was administered. Data were analyzed using SPSS version 25 software. Results The majority of participants were aged 20-25 years, resided in rural areas, and had completed primary education. Most participants were housewives. A significant proportion reported experiencing musculoskeletal pain, predominantly in the second trimester. Associations were found between musculoskeletal pain and both age (p=0.025) and trimester of pregnancy (p=0.008).

show abstract

Section: Discussionmentioning

confidence: 90%

Investigating Musculoskeletal Pain Among Pregnant Women in Dhaka Division: A Cross-Sectional Study

Uddin,

Shumi

2024

Preprint

View full text Add to dashboard Cite

show abstract

“…A meta‐analysis showed that the HCV antibody prevalence in prisons in Asia, America, Europe, Africa, and Australia and Oceania were 21.4%, 10.7%, 25.1%, 11.7%, and 28.4%, respectively 33 . This represents an HCV prevalence of 17.7% in prisons worldwide 33 . HCV RNA prevalence was also lower than anticipated, likely reflecting the fact that many HCV RNA‐positive residents have been identified and treated through the effective reception‐based screening in place in these prisons.…”

Section: Discussionmentioning

confidence: 99%

“…The antibody prevalence in this initiative was also lower than the estimated prevalence in prisons on different continents. A meta‐analysis showed that the HCV antibody prevalence in prisons in Asia, America, Europe, Africa, and Australia and Oceania were 21.4%, 10.7%, 25.1%, 11.7%, and 28.4%, respectively 33 . This represents an HCV prevalence of 17.7% in prisons worldwide 33 .…”

Section: Discussionmentioning

confidence: 99%

Chronic hepatitis C elimination prison initiative: HCV‐intensive test and treat, a whole prisoner population HCV test‐and‐treat program in England

Halford,

Christensen,

Cox

et al. 2023

Health Science Reports

View full text Add to dashboard Cite

Background and AimPrison residents are at high risk for hepatitis C virus (HCV) infection. HCV test‐and‐treat initiatives within prisons provide an opportunity to engage with prison residents and achieve HCV micro‐elimination. The aim of the prison HCV‐intensive test and treat initiative was to screen over 95% of all prison residents for HCV infection within a defined number of days determined by the size of the prison population and to initiate treatment within 7−14 days of a positive HCV RNA diagnosis.MethodsAn HCV‐intensive test and treat toolkit was developed based on learnings from pilot HCV‐intensive test and treat events. From January 2020 to September 2021, 13 HCV‐intensive test and treat events took place at prisons in England selected based on high levels of reception blood‐borne virus testing and good access to peers from The Hepatitis C Trust.ResultsAmong a total of 8487 residents, 8139 (95.9%) underwent testing for HCV. Across the 13 prisons included, HCV antibody and RNA prevalence was 8.2% and 1.5%, respectively. The treatment initiation rate among HCV RNA‐positive individuals (n = 124) was 79.0%.ConclusionThe HCV‐intensive test and treat initiative presented here provides a feasible and rapid test‐and‐treat process to achieve HCV elimination within individual prisons. The HCV‐intensive test and treat toolkit can be adapted for rapid HCV testing and treatment events at other prisons in the United Kingdom and worldwide.

show abstract

“…Incarcerated individuals are particularly susceptible to viral infections both chronically and acutely. Worldwide, the prevalence of HCV is 10%-30% in prisoners, with an overall prevalence of 17.7%[ 20 ]. In 2019, an HAV outbreak occurred at a county jail in Minnesota, U.S.[ 21 ].…”

Section: Viral Hepatitismentioning

confidence: 99%

Current status of disparity in liver disease

Sempokuya¹,

Warner²,

Azawi³

et al. 2022

World J Hepatol

View full text Add to dashboard Cite

Disparities have emerged as an important issue in many aspects of healthcare in developed countries and may be based on race, ethnicity, sex, geographical location, and socioeconomic status. For liver disease specifically, these potential disparities can affect access to care and outcome in viral hepatitis, chronic liver disease, and hepatocellular carcinoma. Shortages in hepatologists and medical providers versed in liver disease may amplify these disparities by compromising early detection of liver disease, surveillance for hepatocellular carcinoma, and prompt referral to subspecialists and transplant centers. In the United States, continued efforts have been made to address some of these disparities with better education of healthcare providers, use of telehealth to enhance access to specialists, reminders in electronic medical records, and modifying organ allocation systems for liver transplantation. This review will detail the current status of disparities in liver disease and describe current efforts to minimize these disparities.

show abstract

Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis

Cited by 18 publications

References 97 publications

Investigating Musculoskeletal Pain Among Pregnant Women in Dhaka Division: A Cross-Sectional Study

Investigating Musculoskeletal Pain Among Pregnant Women in Dhaka Division: A Cross-Sectional Study

Chronic hepatitis C elimination prison initiative: HCV‐intensive test and treat, a whole prisoner population HCV test‐and‐treat program in England

Current status of disparity in liver disease

Contact Info

Product

Resources

About